Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Merck

Merck
1891 FOUNDED
PUBLIC STATUS
50K-55K EMPLOYEES
MRK STOCK SYMBOL
54 INVESTMENTS
$101.36 SHARE PRICE (As of Friday Closing)
Description

Merck KGaA operates three main divisions: pharmaceuticals, life sciences, and performance materials. In the pharmaceutical group, branded drugs represent the majority of sales, with consumer products contributing the rest. The other segments manufacture products for life sciences and industrial customers, such as research labs and liquid crystals for flat-screen televisions. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Specialty Chemicals
Pharmaceuticals
Stock Exchange
ETR
Primary Office
  • Frankfurter Straße 250
  • 64293 Darmstadt
  • Germany

+49 06151 000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Merck’s full profile, request a free trial.

Merck Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$94.43 - $115.42 $44.1B $100.32 $8.58 586K 435M

Merck Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 57,235,163 56,925,568 58,726,662 59,318,851
Revenue 17,476,065 17,507,464 16,371,756 16,618,734
EBITDA 4,022,875 4,191,596 4,761,421 4,878,103
Net Income 3,729,987 3,981,544 2,937,826 1,801,911
Total Assets 43,451,960 42,196,294 42,734,602 40,236,002
Total Debt 10,650,595 10,072,066 12,847,614 13,111,565
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Merck Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Merck‘s full profile, request access.

Request full access to PitchBook

Merck Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bayer Corporate Backed or Acquired Leverkusen, Germany 000000 00.000 000000000 00.000
00000000000 000000 Private Equity-Backed Mexico City, Mexico 000.00 0000000000 000.00
00000000 Corporate Backed or Acquired Basel, Switzerland 000000 000000000000
00000 Corporate Backed or Acquired Mumbai, India 00000 00000000
000000000000000 Corporation Brentford, United Kingdom 000000 00000000000
To view this company’s complete list of competitors, request access »

Merck Investments & Acquisitions (54)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000000 06-May-2019 000000000000000000 0000 Application Software 000 00000000 00.0
000000 000000000 08-Apr-2019 000000000000000000 00.000 Specialty Chemicals 0000000 00000000 00.0
0000000000 29-Mar-2019 000000000000000000 Outcome Management (Healthcare)
00000000 (00000 00 19-Nov-2018 00000 0000000 Business/Productivity Software 0000000 00000000 00.0
Sutro Biopharma 26-Jul-2018 Later Stage VC 000.00 Drug Delivery
To view this company’s complete investment and acquisition history, request access »

Merck Exits (7)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000 26-Jul-2018 00000 00000 00 000.00 Completed
  • 12 buyers
000000 07-Sep-2012 000000000 00000 00 00000 Completed
  • 00000
0000000 0000000000 18-Jul-2008 00000 00000 00 0000 Completed
  • 4 buyers
00000000 11-Jun-2007 00000 00000 00 000.00 Completed
  • 00000
Bayer Schering Pharma 08-Jun-2006 Secondary Transaction - Private Completed
To view this company’s complete exits history, request access »

Merck Subsidiaries (16)

Company Name Industry Location Founded
Merck Innovation Center Accelerator/Incubator Darmstadt, Germany 2015
0000000000 0000000 Other Software Evanston, IL 0000
00000 00000000 Corporate Venture Capital Amsterdam, Netherlands 0000
00000000 000000000 Drug Discovery San Mateo, CA 0000
000000 00000000000 Biotechnology Burlington, Canada 0000
To view this company’s complete subsidiary history, request access »

Merck Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Merck‘s full profile, request access.

Request full access to PitchBook

Merck Executive Team (40)

Name Title Board
Seat
Contact
Info
Stephan Oschmann Ph.D Chairman of the Executive Board & Chief Executive Officer
Marcus Kuhnert Ph.D Member of the Executive Board & Chief Financial Officer
Rehan Verjee Executive Vice President, Chief Marketing Officer & Chief Strategy Officer
Kai Beckmann Ph.D Chief Administration Officer & Member of the Executive Board
Aatraye Almast Inhouse Consulting

9 Former Executives

You’re viewing 5 of 40 executives. Get the full list »

Merck Board Members (8)

Name Representing Role Since Contact
Info
00000 00000000 Self Board Member & Chief Executive Officer, Life Science & Performance Materials 000 0000
000000000 00000 00.0 Merck Chairman 000 0000
0000 00000000 Merck Senior Director, Finance & Board Member 000 0000
000 00000000 00.0 Merck Chief Administration Officer & Member of the Executive Board 000 0000
000000 0000000 00.0 Merck Member of the Executive Board & Chief Financial Officer 000 0000

2 Former Board Members

You’re viewing 5 of 8 board members. Get the full list »